Benefits of an integrated approach to gene therapy development and manufacturing
2023-06-08 · 16:00
Developing and commercializing viral vectors for gene therapies is a complex and expensive process. It requires careful consideration of various key elements, including regulatory compliance, process design, specifications, and supply chain strategy. To ensure timely and cost-effective project delivery, it is crucial to understand the critical aspects of this journey and mitigate potential challenges.
An integrated approach to gene therapy development and manufacturing offers several benefits over customized solutions. These benefits includes effective coordination of diverse functions, streamlined decision-making, and improved resource utilization. With over 20 years of experience, Thermo Fisher Scientific viral vector services have demonstrated expertise in moving products from discovery to commercialization through expertise, capabilities, and end-to-end solutions.
Key learning objectives:
- Understand the key deliverables at each stage of the viral vector product lifecycle
- Evaluate the effectiveness of integrated solutions versus customized strategies in overcoming development and manufacturing challenges
- Explore CDMO/CRO solutions for viral vectors from Thermo Fisher Scientific, including different platforms, Quick-to-Clinic, accelerated toxicology path, and end-to-end development and manufacturing
Further Information: www.event.on24.com/wcc/